ABCC1 p.Tyr1190Ala
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 15652236
[PubMed]
Conseil G et al: "Role of two adjacent cytoplasmic tyrosine residues in MRP1 (ABCC1) transport activity and sensitivity to sulfonylureas."
No.
Sentence
Comment
59
Tyr substitutions were generated in the pGEM-3Z plasmids according to the manufacturer`s instructions with the following mutagenic primers (substituted nucleotides are in bold) obtained from Integrated DNA Technologies: Y1189A (50 -GAT GCT GGG GAT CGC GGC CTT CTG GTT CTC-30 ), Y1189S (50 -GAT GCT GGG GTA ACT GGC CTT CTG G-30 ), Y1190A (50 -C CAC GAT GCT CGG GGC ATA GGC CTT C-30 ), Y1190S (50 -C GAT GCT GGG ACT ATA GGC CTT C30 ).
X
ABCC1 p.Tyr1190Ala 15652236:59:330
status: NEW115 Expression levels and organic anion uptake by Tyr1189 and Tyr1190 mutant MRP1 proteins Replacement of Tyr1189 and Tyr1190 with Ala and Ser was done by site-directed mutagenesis and then HEK293T cells were transfected to express the mutant and wild-type MRP1 proteins.
X
ABCC1 p.Tyr1190Ala 15652236:115:114
status: NEW119 As shown in Fig. 3B, the ability of the mutants to support LTC4 uptake after 3 min was reduced by approximately 55 and 25% for Y1189A and Y1189S, respectively, and by approximately 40 and 50% for Y1190A and Y1190S, compared to wild-type MRP1.
X
ABCC1 p.Tyr1190Ala 15652236:119:196
status: NEW121 E217bG uptake by the Y1189A and Y1189S mutants was reduced by 30%, and by 55-65% for the Y1190A and Y1190S mutants.
X
ABCC1 p.Tyr1190Ala 15652236:121:89
status: NEW122 E13SO4 uptake was reduced by 35% in the case of Y1189S and by 60-65% for the Y1189A, Y1190A and Y1190S mutants.
X
ABCC1 p.Tyr1190Ala 15652236:122:85
status: NEW129 As shown in Fig. 4B, Y1189A, Y1189S, Y1190A and Y1190S exhibited a moderate (10-30%) decrease in azido-ATP labeling at 4 8C.
X
ABCC1 p.Tyr1190Ala 15652236:129:37
status: NEW130 When the amount of azido-ADP trapped by vanadate under hydrolysis conditions at 37 8C was measured, the Ala-substituted mutants Y1189A and Y1190A exhibited a reduction of 30-40% compared to wild-type MRP1, whereas little or no ( 10%) decrease in trapping was observed for the Ser-substituted Y1189S and Y1190S mutants (Fig. 4C).
X
ABCC1 p.Tyr1190Ala 15652236:130:139
status: NEW133 (A) Immunodot blot of membrane vesicles (0.5 and 1 mg protein) prepared from HEK293T cells transfected with wild-type (WT-MRP1) and mutant (Y1189A, Y1189S, Y1190A, Y1190S) MRP1 cDNAs.
X
ABCC1 p.Tyr1190Ala 15652236:133:156
status: NEW138 ; Y1189S, ~; Y1190A, *; Y1190S, *) cDNAs.
X
ABCC1 p.Tyr1190Ala 15652236:138:13
status: NEW143 Table 1 Summary of transport activities for Tyr1189 and Tyr1190 mutants of MRP1 Mutant %Wild-type MRP1 uptake activitya LTC4 b E217bG E13SO4 MTX GSH Y1189A 45 70 40 35 10 Y1189S 75 70 65 35 30 Y1190A 60 45 40 35 20 Y1190S 50 35 35 25 25 a The values shown are means of triplicate determinations in a single experiment and are representative of results obtained in two to three independent experiments. Values have been corrected for different MRP1 expression levels according to the immunoblot shown Fig. 3A.
X
ABCC1 p.Tyr1190Ala 15652236:143:193
status: NEW154 (A) Immunoblot of membrane vesicles (1 mg protein) prepared from HEK293T cells transfected with wild-type (WT-MRP1a, b, c), and mutant (Y1189A, Y1189S, Y1190A, Y1190S) MRP1 cDNAs as in Fig 3A. (B) Membrane vesicles (20 mg protein) were incubated with 5 mM [a-32 P]-8N3-ATP at 4 8C for 5 min in transport buffer containing 5 mM MgCl2. Samples were photo-crosslinked, resolved by SDS-PAGE and exposed to film.
X
ABCC1 p.Tyr1190Ala 15652236:154:152
status: NEW164 Ala/Ser MRP1 mutants (Y1189A, Y1189S, Y1190A, Y1190S).
X
ABCC1 p.Tyr1190Ala 15652236:164:38
status: NEW177 Membrane vesicles (2.5 mg protein) prepared from transfected HEK293T cells expressing wild-type MRP1 (WT-MRP1) (A), Tyr1189 mutants Y1189A (B), and Y1189S (C), and Tyr1190 mutants Y1190A (D) and Y1190S (E) were incubated for 3 min at 37 8C with [3 H]E13SO4 (300 nM, 100 nCi) and ATP or AMP.
X
ABCC1 p.Tyr1190Ala 15652236:177:180
status: NEW153 (A) Immunoblot of membrane vesicles (1 mg protein) prepared from HEK293T cells transfected with wild-type (WT-MRP1a, b, c), and mutant (Y1189A, Y1189S, Y1190A, Y1190S) MRP1 cDNAs as in Fig 3A. (B) Membrane vesicles (20 mg protein) were incubated with 5 mM [a-32 P]-8N3-ATP at 4 8C for 5 min in transport buffer containing 5 mM MgCl2. Samples were photo-crosslinked, resolved by SDS-PAGE and exposed to film.
X
ABCC1 p.Tyr1190Ala 15652236:153:152
status: NEW163 Ala/Ser MRP1 mutants (Y1189A, Y1189S, Y1190A, Y1190S).
X
ABCC1 p.Tyr1190Ala 15652236:163:38
status: NEW176 Membrane vesicles (2.5 mg protein) prepared from transfected HEK293T cells expressing wild-type MRP1 (WT-MRP1) (A), Tyr1189 mutants Y1189A (B), and Y1189S (C), and Tyr1190 mutants Y1190A (D) and Y1190S (E) were incubated for 3 min at 37 8C with [3 H]E13SO4 (300 nM, 100 nCi) and ATP or AMP.
X
ABCC1 p.Tyr1190Ala 15652236:176:180
status: NEW